Académique Documents
Professionnel Documents
Culture Documents
:A comparison of efficacy of single topical permethrin and single oral ivermectin in the treatment of scabies
Penulis
Nama jurnal dan tahun terbit:Journal of Pakistan Association of Dermatologists 2012 Analisis PICO Question components P-patient or population Describe the most important : Your Question Perempuan 11 tahun dengan skabies
characteristics of the patient I-intervention; prognostic factor; exposure Permethrin Describe the main intervention C-comparison (if appropriate) Describe the main alternative being considered O-outcome Describe what youre trying to Manfaat Ivermectin
Topik
No
Keterangan
Ditemukan di halaman berapa, jelaskan menggambarkan Halaman 45: A comparison of efficacy of single topical permethrin and single oral ivermectin in the treatment of scabies. Dari kalimat diatas
Judul abstrak
dan 1
1. Judul
pasien scabies. 2. Abstrak kesimpulan memberikan yang Halaman 45 pada bagian abstrak objektif :
dan apa yang ditemukan To compare the efficacy of (hasil) topical permethrin and oral ivermectin in treatment of scabies Dari kalimat diatas bahwa ini
diterangkan penelitian
permethrin and oral ivermectin when used in treatment of scabies. Hasil dari penelitian ialah tidak ditemukan perbedaan yang
signifikan antara manfaat topikal Permethrin Ivermectin Introduksi Latarbelakang 2 Menjelaskan latar belakang yang Halaman 45 pada bagian ilmiah dan rasional mengapa abstrak background: Scabies is a common health problem worldwide. Among available topical bagian dibandingkan oral
effective scabicide with few side effects. Ivermectin is the only oral scabicide
available. It is effective, inexpensive and easy to administer with no known drug interactions and limited side effects. Dari kalimat diatas
kesehatan dunia saat ini. Permethrin adalah obat topical yang paling
terbatas dilakukan
sehingga penelitian
untuk mengetahui efek mana yang lebih baik Tujuan 3 Menentukan tujuan spesifik, Terdapat pada halaman 46 pada bagian introduksi
paragraf ke 6: Our clinical trial aimed to compare the efficacy of oral ivermectin in a single dose of 200g/kg with that of once topical 5% permethrin. Tujuan percobaan klinis ini adalah untuk
dan
ivermectin
diajukan tidak dijelaskan. Bahan dan Cara Bahan 4 Menjelaskan desain penelitian Halaman 46 pada bagian pasien dan metode di
experimental study. Desain penelitian adalah quasi-eksperimental dengan pasien. Subyek penelitian 5 Menjelaskan kriteria subyek Halaman 46 bagian pasien dan metode pada paragraf 3: Patients of either sex with a confirmed diagnosis of scabies, aged 18-60years were enrolled. randomisasi
Confirmation was done by burrow detection by ink method and microscopic evidence of Sarcoptes
feces
called
scybala.
patients, hypersensitivity to permethrin or ivermectin, prior use of topical or systemic scabicide in last 4 weeks, patients on
drugs for any systemic or cutaneous indication Kriteria subjek penelitian adalah pasien pria atau wanita dengan diagnosis scabies yang berusia 1860 tahun. Sedangkan eksklusinya
kriteria
hipersensitifitas, dengan
radioterapi,
dilakukan pada tiap kelompok pasien dan metode, yaitu : perlakuan dengan detail. A total of 120, otherwise healthy, patients with scabies were enrolled study and randomly divided in 2 groups of 60 each. After written
recorded on a pre designed pro forma on the first day, before starting treatment was noted. In group A, topical permethrin 5% in lotion form was used. Patients received explicit written instructions about topical
application. It had to cover the entire body (from neck to toe) and be kept there for 10-12 hours followed by a bath. In group B, ivermectin tablets were taken by the patient in the presence of the investigator. In both groups patients were advised not to use any other antiscabietic medicine during the study period. Bed covers and personal clothes had to be washed with soap and water after completion of therapy. All the
patients were given antihistamines at bed time during 1st week. Secondary infection, when present, was treated with a 7-day course of antibiotic. The contacts of the patients of both groups were treated at the same time with same treatment. However, children under 5 years of age and pregnant or lactating women in the
Dibagi
secara
acak
outcome, baik utama maupun hasil, yaitu : sekunder, At day 7, cure rate was similar in two groups
(p=0.54). Marginally, more patients in group B had very good response as compared to group A.
Treatment failure was not seen in any patient. Final assessment was made at day 14. Results revealed 40 patients (66.7 %) in both groups had cure.
Treatment failure was also equal in both groups. Treatment efficacy after 2 weeks was categorized as
effective
in
91.3%
and
(Table 4
relapses
minggu
kedua
86,3% untuk ivermectin. Namun dari hasil statistic tidak ada perbedaan
yang signifikan. Besar sampel 8 Menyebutkan jumlah sampel dan Halaman 45 bagian pasien bagaimana diperoleh. sampel tersebut dan metode, yaitu: A total of 120, otherwise healthy, scabies patients were with
enrolled
study and randomly divided in 2 groups of 60 each. Total subjek adalah 120 responden yang dibagi secara acak menjadi dua kelompok. Metode statistik 9 Metode digunakan statistik untuk yang yang Halaman 47 di bagian
hasil
SPSS
version
10
was
used for analysis Analisisi menggunakan versi 10 Hasil Alur penelitian 10 Menjelaskan waktu penelitian Waktu penelitian dijelaskan dan follow-up pada halaman 46 dibagian pasien dan metode, yaitu: The study was completed in 11 months. Waktu penelitian adalah 11 bulan. Sedangkan untuk follow up dijelaskan pada halaman 47 bagian evaluasi, yaitu: All 14. Semua pasien the patients were penelitian SPSS
Outcomedan estimasi
11
Menjelaskan dan
outcome dari
tambahan
10
tabel 3
hasil, Halaman
49
di
bagian
hipotesis diskusi, yaitu: The main limitation of our study was that ivermectin was not given to children below 5 years of age (or <15kg) and to pregnant or lactating women due to concerns regarding its use in these conditions keeping in mind possibility of
penelitian, sumber bias atau ketidaktepatan yang dan bahaya dengan dan
berhubungan analisis
keragaman outcome.
increased penetrance of drug through the immature blood-brain Another limitation barrier. was
inability to trace all the contacts and treat them. Further required studies to are
evaluate
efficacy and safety of this drug in children. Keterbatasan penelitian ivermectin diberikan pada ini dari adalah tidak pasien
11
Kedepannya diharapkan ada penelitian maupun evaluasi tersebut. Generalizability 13 Apakah hasil penelitian dapat Tidak dijelaskan didalam digeneralisasikan masyarakat. Overall evidence 14 Interpretasi hasil terkini. dalam umum terhadap Tidak dijelaskan di dalam bukti jurnal. di jurnal untuk hal
konteks
12